GeneCentric

Life Sciences
Written By Sam Carter

GeneCentric Therapeutics applies its proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of prevision cancer drugs while improving patient outcomes.

—

Learn more at: genecentric.com

Sam Carter
Previous

First Ascent Biomedical
Next

Graphiant